UH15-38
UH15-38 is a potent RIPK3 inhibitor with an IC50 value of 20 nM. UH15-38 blocks IAV (influenza A virus) -activated necroptosis. UH15-38 dampens IAV-induced lung injury[1].
Product Specifications
CAS Number
2540881-21-6
UNSPSC
12352005
Target
Influenza Virus; Necroptosis; RIP kinase
Type
Reference compound
Related Pathways
Anti-infection; Apoptosis
Applications
COVID-19-anti-virus
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/uh15-38.html
Purity
99.80
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CN1CCN(CC1)C2=CC(NC3=NC=C4C=C(C(N(C4=C3)C)=O)C5=CC(O)=CC=C5)=CC=C2
Molecular Formula
C26H27N5O2
Molecular Weight
441.52
References & Citations
[1]Gautam A, et al. Necroptosis blockade prevents lung injury in severe influenza. Nature. 2024 Apr;628 (8009) :835-843.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
RIPK3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Purified Anti-Human CD61 Antibody[VI-PL2]](https://cdn.genprice.uk/products/763/68dd14c4061270361e7d70db/imageurl/e-ab-f11660p.webp)
BNC403493-100 1x 100 µL
PAI-RBP1 / SERBP1 / SERPINE1 (SERBP1/3493), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LY422279 100 µg
ANKRD20A5P (NM_001029999) Human Over-expression Lysate
Sign In for Pricing
View Details